Financial results: Bioxyne; Rua Bioscience; Bod Science; Avecho; Wellnex Life; MGC Pharma; Cannasouth by Steve Jones March 7, 2024March 7, 2024 Bioxyne was hit with an impairment charge of A$11.5 million in the first half of FY24 […]
Company news: Rua Bioscience; Emyria; InhaleRx; Cannasouth; Roots: Creso Pharma; Epsilon by cannabiz team December 2, 2021April 29, 2024
